Ngl Fine Chem Limited

NGLFINE NSE Healthcare Pharmaceuticals
₹2,657.20
-2.51%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.37.
  • Comfortable interest cover: operating profit covers interest about 16 times.
  • Return on equity is healthy at 17.4%.
  • Return on capital employed is healthy at 18.6%.
  • Net profit margin is 9.6%.
  • Sales have compounded about 14% a year over five years.
  • Pays a dividend (yield about 0.07%).
  • Has paid a dividend in each of the last 5 years on record.
  • Promoters hold a majority stake (72.49%).

!Watch-points

  • Profit growth has been slow over five years (about -1% a year).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreSafe zone
4.05

In Altman’s original study, companies in this range showed a low incidence of financial distress.

Computed without the working-capital term (current-asset split not available for this stock).

Piotroski F-ScoreModerate
5 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 1,642 Cr
Current Price₹ 2,657.20
High / Low₹ 3,602.00 / 1,271.00
Stock P/E28.652145
Book Value₹ 533.00
Dividend Yield0%
ROCE18.60%
ROE17.40%
Face Value₹ 5.00
Debt to Equity0.37
PEG Ratio0.78
EV / EBITDA17.65
Industry PE35.70
P/B Ratio4.9861326
EPS₹ 77.91
Debt₹ 123 Cr
PAT Margin9.58%
Cash PAT₹ 68 Cr
ICR16.00
Promoter Holding72.49%
FII Holding0.05%
DII Holding0.02%
Public Holding27.43%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Compounded Sales Growth
10 Years
5 Years 14.00%
3 Years 22.00%
TTM 40.00%
Compounded Profit Growth
10 Years
5 Years -1.00%
3 Years 37.00%
TTM 174.00%
Stock Price CAGR
10 Years 22.00%
5 Years -2.00%
3 Years 10.00%
1 Year 84.00%
Return on Equity
10 Years
5 Years 15.00%
3 Years 14.00%
Last Year 17.00%
Educational data only. Not a recommendation to buy, sell or hold any security.